The present invention relates to compounds of formula (AA) (I) and (X):
useful in treating Alzheimer's disease and other similar diseases. These compounds include inhibitors of the beta-secretase enzyme that are useful in the treatment of Alzheimer's disease and other diseases characterized by deposition of A beta peptide in a mammal. The compounds of the invention are useful in pharmaceutical compositions and methods of treatment to reduce A beta peptide formation.
substantially added to the surface. Theoretically, the highest occupied molecular orbital (HOMO), lowest unoccupied molecular orbital (LUMO) and various global reactivity descriptors were also computed by the density functional theory (DFT/B3LYP) approach with a 6-311G(d, p) basis set in the ground state on the geometrically optimized structure in the gas phase.